Characterization of a regulatory network of peptide antibiotic detoxification modules in lactobacillus casei BL23

Applied and Environmental Microbiology

Volumn 79, Issue 10, 2013, Pages 3160-3170

  Revilla Guarinos, Ainhoa ^a   Gebhard, Susanne ^b   Alcántara, Cristina ^a   Staroń, Anna ^b   Mascher, Thorsten ^b   Zúñiga, Manuel ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL PEPTIDE; FUNCTIONAL UNITS; LACTOBACILLUS CASEI; PEPTIDE ANTIBIOTICS; REGULATORY NETWORK; SIGNAL TRANSDUCTION PATHWAYS; TRANSCRIPTIONAL LEVELS; TWO-COMPONENT SYSTEMS;

AMINO ACIDS; DETOXIFICATION; PEPTIDES; PHOSPHOLIPIDS; SIGNAL TRANSDUCTION;

ANTIBIOTICS;

ANTIMICROBIAL CATIONIC PEPTIDE; BACITRACIN; BACTERIAL PROTEIN; NISIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; BIOCHEMISTRY; DETOXIFICATION; ENZYME ACTIVITY; GENE EXPRESSION; MOLECULAR ANALYSIS; MUTATION; PEPTIDE; PROBIOTICS;

ADAPTATION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; BINDING SITE; CONSENSUS SEQUENCE; DRUG EFFECT; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; LACTOBACILLUS CASEI; METABOLISM; MICROBIAL SENSITIVITY TEST; OPERON; PLEIOTROPY; PROMOTER REGION; REGULON; SPECIES DIFFERENCE;

ADAPTATION, PHYSIOLOGICAL; ANTIMICROBIAL CATIONIC PEPTIDES; BACITRACIN; BACTERIAL PROTEINS; BINDING SITES; CONSENSUS SEQUENCE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC PLEIOTROPY; GENOME, BACTERIAL; LACTOBACILLUS CASEI; MICROBIAL SENSITIVITY TESTS; NISIN; OPERON; PROMOTER REGIONS, GENETIC; REGULON; SPECIES SPECIFICITY; TRANSCRIPTION, GENETIC;

EID: 84877127954     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00178-13     Document Type: Article

References (64)

1. de Vrese M, Schrezenmeir J. 2008. Probiotics, prebiotics, and synbiotics. Adv. Biochem. Eng. Biotechnol. 111:1- 66.
2. Kleerebezem M, Vaughan EE. 2009. Probiotic and gut lactobacilli and bifidobacteria: molecular approaches to study diversity and activity. Annu. Rev. Microbiol. 63:269-290.
3. Corcoran BM, Stanton C, Fitzgerald G, Ross RP. 2008. Life under stress: the probiotic stress response and how it may be manipulated. Curr. Pharm. Des. 14:1382-1399.
4. Cunliffe RN. 2003. Alpha-defensins in the gastrointestinal tract. Mol. Immunol. 40:463- 467.
5. Dommett R, Zilbauer M, George JT, Bajaj-Elliott M. 2005. Innate immune defence in the human gastrointestinal tract. Mol. Immunol. 42: 903-912.
6. Gallo RL, Hooper LV. 2012. Epithelial antimicrobial defence of the skin and intestine. Nat. Rev. Immunol. 12:503-516.
7. Hancock RE, Diamond G. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol. 8:402- 410.
8. Peschel A. 2002. How do bacteria resist human antimicrobial peptides? Trends Microbiol. 10:179-186.
9. Cotter PD, Hill C, Ross RP. 2005. Bacteriocins: developing innate immunity for food. Nat. Rev. Microbiol. 3:777-788.
10. Gálvez A, Abriouel H, López RL, Ben Omar N. 2007. Bacteriocin-based strategies for food biopreservation. Int. J. Food Microbiol. 120:51-70.
11. Hancock REW. 1997. Peptide antibiotics. Lancet 349:418-422.
12. Peschel A, Sahl HG. 2006. The co-evolution of host cationic antimicrobial peptides and microbial resistance. Nat. Rev. Microbiol. 4:529-536.
13. Nishie M, Nagao J, Sonomoto K. 2012. Antibacterial peptides "bacterio-cins": an overview of their diverse characteristics and applications. Biocontrol Sci. 17:1-16.
14. Breukink E, Wiedemann I, van Kraaij C, Kuipers OP, Sahl H, de Kruijff B. 1999. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286:2361-2364.
15. Brötz H, Josten M, Wiedemann I, Schneider U, Götz F, Bierbaum G, Sahl HG. 1998. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30:317-327.
16. Wiedemann I, Breukink E, van Kraaij C, Kuipers OP, Bierbaum G, de Kruijff B, Sahl HG. 2001. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276:1772-1779.
17. Dintner S, Staroń A, Berchtold E, Petri T, Mascher T, Gebhard S. 2011. Coevolution of ABC transporters and two-component regulatory systems as resistance modules against antimicrobial peptides in Firmicutes bacteria. J. Bacteriol. 193:3851-3862.
18. Guo L, Lim KB, Gunn JS, Bainbridge B, Darveau RP, Hackett M, Miller SI. 1997. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 276:250-253.
19. Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 2007. The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol. Microbiol. 66:1136-1147.
20. Li M, Lai Y, Villaruz AE, Cha DJ, Sturdevant DE, Otto M. 2007. Gram-positive three-component antimicrobial peptide-sensing system. Proc. Natl. Acad. Sci. U. S. A. 104:9469-9474.
21. Staroń A, Finkeisen DE, Mascher T. 2011. Peptide antibiotic sensing and detoxification modules of Bacillus subtilis. Antimicrob. Agents Chemother. 55:515-525.
22. Gao R, Stock AM. 2009. Biological insights from structures of twocomponent proteins. Annu. Rev. Microbiol. 63:133-154.
23. Ninfa AJ, Magasanik B. 1986. Covalent modification of the glnG product, NRI, by the glnL product, NRII, regulates the transcription of the glnALG operon in Escherichia coli. Proc. Natl. Acad. Sci. U. S. A. 83:5909-5913.
24. Nixon BT, Ronson CW, Ausubel FM. 1986. Two-component regulatory systems responsive to environmental stimuli share strongly conserved domains with the nitrogen assimilation regulatory genes ntrB and ntrC. Proc. Natl. Acad. Sci. U. S. A. 83:7850-7854.
25. Stock AM, Robinson VL, Goudreau PN. 2000. Two-component signal transduction. Annu. Rev. Biochem. 69:183-215.
26. Coumes-Florens S, Brochier-Armanet C, Guiseppi A, Denizot F, Foglino M. 2011. A new highly conserved antibiotic sensing/resistance pathway in Firmicutes involves an ABC transporter interplaying with a signal transduction system. PLoS One 6:e15951. doi:10.1371/journal.pone.0015951.
27. Gebhard S, Mascher T. 2011. Antimicrobial peptide sensing and detoxification modules: unravelling the regulatory circuitry of Staphylococcus aureus. Mol. Microbiol. 81:581-587.
28. Joseph P, Fichant G, Quentin Y, Denizot F. 2002. Regulatory relationship of two-component and ABC transport systems and clustering of their genes in the Bacillus/Clostridium group, suggest a functional link between them. J. Mol. Microbiol. Biotechnol. 4:503-513.
29. Mascher T. 2006. Intramembrane-sensing histidine kinases: a new family of cell envelope stress sensors in Firmicutes bacteria. FEMS Microbiol. Lett. 264:133-144.
30. Bernard R, Guiseppi A, Chippaux M, Foglino M, Denizot F. 2007. Resistance to bacitracin in Bacillus subtilis: unexpected requirement of the BceAB ABC transporter in the control of expression of its own structural genes. J. Bacteriol. 189:8636-8642.
31. Ohki R, Giyanto Tateno K, Masuyama W, Moriya S, Kobayashi K, Ogasawara N. 2003. The BceRS two-component regulatory system induces expression of the bacitracin transporter, BceAB, in Bacillus subtilis. Mol. Microbiol. 49:1135-1144.
32. Rietkötter E, Hoyer D, Mascher T. 2008. Bacitracin sensing in Bacillus subtilis. Mol. Microbiol. 68:768-785.
33. Ouyang J, Tian XL, Versey J, Wishart A, Li YH. 2010. The BceABRS four-component system regulates the bacitracin-induced cell envelope stress response in Streptococcus mutans. Antimicrob. Agents Chemother. 54:3895-3906.
34. Alcántara C, Revilla-Guarinos A, Zúñiga M. 2011. Influence of twocomponent signal transduction systems of Lactobacillus casei BL23 on tolerance to stress conditions. Appl. Environ. Microbiol. 77:1516-1519.
35. Leloup L, Ehrlich SD, Zagorec M, Morel-Deville F. 1997. Singlecrossover integration in the Lactobacillus sake chromosome and insertional inactivation of the ptsI and lacL genes. Appl. Environ. Microbiol. 63:2117-2123.
36. Broadbent JR, Neeno-Eckwall EC, Stahl B, Tandee K, Cai H, Morovic W, Horvath P, Heidenreich J, Perna NT, Barrangou R, Steele JL. 2012. Analysis of the Lactobacillus casei supragenome and its influence in species evolution and lifestyle adaptation. BMC Genomics 13:533. doi:10.1186 /1471-2164-13-533.
37. Mazé A, Böel G, Zúñiga M, Bourand A, Loux V, Yebra MJ, Monedero V, Correia K, Jacques N, Beaufils S, Poncet S, Joyet P, Milohanic E, Casaregola S, Auffray Y, Pérez-Martínez G, Gibrat JF, Zagorec M, Francke C, Hartke A, Deutscher J. 2010. Complete genome sequence of the probiotic Lactobacillus casei strain BL23. J. Bacteriol. 192:2647-2648.
38. Sambrook J, Fritsch EF, Maniatis T. 1989. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
39. Posno M, Leer RJ, van Luijk N, van Giezen MJ, Heuvelmans PT, Lokman BC, Pouwels PH. 1991. Incompatibility of Lactobacillus vectors with replicons derived from small cryptic Lactobacillus plasmids and segregational instability of the introduced vectors. Appl. Environ. Microbiol. 57:1822-1828.
40. Matsuo M, Oogai Y, Kato F, Sugai M, Komatsuzawa H. 2011. Growthphase dependence of susceptibility to antimicrobial peptides in Staphylococcus aureus. Microbiology 157:1786-1797.
41. Meehl M, Herbert S, Gotz F, Cheung A. 2007. Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51:2679-2689.
42. Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F. 1999. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274:8405- 8410.
43. Landete JM, García-Haro L, Blasco A, Manzanares P, Berbegal C, Monedero V, Zúñiga M. 2010. Requirement of the Lactobacillus casei MaeKR two-component system for L-malic acid utilization via a malic enzyme pathway. Appl. Environ. Microbiol. 76:84-95.
44. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A, Speleman F. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
45. Pfaffl MW, Horgan GW, Dempfle L. 2002. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30:e36.
46. Neuhaus FC, Heaton MP, Debabov DV, Zhang Q. 1996. The dlt operon in the biosynthesis of D-alanyl-lipoteichoic acid in Lactobacillus casei. Microb. Drug Resist. 2:77- 84.
47. Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA. 2001. Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with L-lysine. J. Exp. Med. 193:1067-1076.
48. Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jansch L. 2006. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol. Microbiol. 62:1325-1339.
49. Jenssen H, Hamill P, Hancock RE. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511.
50. Dobson A, Cotter PD, Ross RP, Hill C. 2012. Bacteriocin production: a probiotic trait? Appl. Environ. Microbiol. 78:1- 6.
51. Falord M, Karimova G, Hiron A, Msadek T. 2012. GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 56:1047-1058.
52. Hiron A, Falord M, Valle J, Debarbouille M, Msadek T. 2011. Bacitracin and nisin resistance in Staphylococcus aureus: a novel pathway involving the BraS/BraR two-component system (SA2417/SA2418) and both the BraD/BraE and VraD/VraE ABC transporters. Mol. Microbiol. 81:602- 622.
53. Kawada-Matsuo M, Yoshida Y, Nakamura N, Komatsuzawa H. 2011. Role of two-component systems in the resistance of Staphylococcus aureus to antibacterial agents. Virulence 2:427- 430.
54. Lubelski J, Rink R, Khusainov R, Moll GN, Kuipers OP. 2008. Biosynthesis, immunity, regulation, mode of action and engineering of the model lantibiotic nisin. Cell. Mol. Life Sci. 65:455- 476.
55. Sahl HG, Bierbaum G. 1998. Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria. Annu. Rev. Microbiol. 52:41-79.
56. Schnell N, Entian KD, Schneider U, Götz F, Zähner H, Kellner R, Jung G. 1988. Prepeptide sequence of epidermin, a ribosomally synthesized antibiotic with four sulphide-rings. Nature 333:276-278.
57. Siegers K, Entian KD. 1995. Genes involved in immunity to the lantibiotic nisin produced by Lactococcus lactis 6F3. Appl. Environ. Microbiol. 61:1082-1089.
58. Herbert S, Bera A, Nerz C, Kraus D, Peschel A, Goerke C, Meehl M, Cheung A, Götz F. 2007. Molecular basis of resistance to muramidase and cationic antimicrobial peptide activity of lysozyme in staphylococci. PLoS Pathog. 3:e102. doi:10.1371/journal.ppat.0030102.
59. Mandin P, Fsihi H, Dussurget O, Vergassola M, Milohanic E, Toledo-Arana A, Lasa I, Johansson J, Cossart P. 2005. VirR, a response regulator critical for Listeria monocytogenes virulence. Mol. Microbiol. 57:1367- 1380.
60. Collins B, Curtis N, Cotter PD, Hill C, Ross RP. 2010. The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics. Antimicrob. Agents Chemother. 54:4416-4423.
61. Neuhaus FC, Baddiley J. 2003. A continuum of anionic charge: structures and functions of D-alanyl-teichoic acids in gram-positive bacteria. Microbiol. Mol. Biol. Rev. 67:686-723.
62. Ernst CM, Peschel A. 2011. Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids. Mol. Microbiol. 80:290-299.
63. Ernst CM, Staubitz P, Mishra NN, Yang SJ, Hornig G, Kalbacher H, Bayer AS, Kraus D, Peschel A. 2009. The bacterial defensin resistance protein MprF consists of separable domains for lipid lysinylation and antimicrobial peptide repulsion. PLoS Pathog. 5:e1000660. doi:10.1371 /journal.ppat.1000660.
64. Boyd DA, Cvitkovitch DG, Bleiweis AS, Kiriukhin MY, Debabov DV, Neuhaus FC, Hamilton IR. 2000. Defects in D-alanyl-lipoteichoic acid synthesis in Streptococcus mutans results in acid sensitivity. J. Bacteriol. 182:6055- 6065.